Latest Schedule 13G passive stakes

Several entities affiliated with Millennium Management have filed a Schedule 13G, confirming their beneficial ownership of Perspective Therapeutics, Inc. common stock.

First Wilshire Securities Management, Inc. has disclosed beneficial ownership of 4.98% of Silicom Ltd's common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, disclosing a minimal beneficial ownership of 20 shares in Reviva Pharmaceuticals, representing 0.00% of the class.

Barclays PLC has filed a Schedule 13G, disclosing a minimal beneficial ownership of 20 shares in Reviva Pharmaceuticals, representing 0.00% of the class.

Millennium Management and affiliated entities have filed a Schedule 13G amendment, reporting no beneficial ownership of Zepp Health Corporation's Class A Ordinary Shares.

Barclays PLC has filed a Schedule 13G, reporting a beneficial ownership of 0.17% in Tavia Acquisition Corp's common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting a beneficial ownership of 0.17% in Tavia Acquisition Corp's common stock as of June 30, 2026.

Barclays PLC has updated its Schedule 13G filing to reflect a 0.04% beneficial ownership in Range Capital Acquisition Co. as of June 30, 2026.

Barclays PLC has updated its Schedule 13G filing to reflect a 0.04% beneficial ownership in Range Capital Acquisition Co. as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 0.6% of Soren Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 0.6% of Soren Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

David S. Nagelberg and the David S. Nagelberg 2003 Revocable Trust have increased their beneficial ownership of PAVmed Inc. common stock to 8.8% and 5.9% respectively.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Origin Materials, Inc. common stock.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Origin Materials, Inc. common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 3.8% of Launch Two Acquisition Corp.'s Class A Ordinary Shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 3.8% of Launch Two Acquisition Corp.'s Class A Ordinary Shares as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting a 4.54% beneficial ownership stake in Madison Square Garden Entertainment Corp. as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting a 4.54% beneficial ownership stake in Madison Square Garden Entertainment Corp. as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 4.13% of Newhold Investment Corp II-A's common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 4.13% of Newhold Investment Corp II-A's common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 3.17% of Zentalis Pharmaceuticals Inc. common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 3.17% of Zentalis Pharmaceuticals Inc. common stock as of June 30, 2026.

Barclays PLC has updated its beneficial ownership filing for Everspin Technologies Inc., reporting a 1.89% stake as of June 30, 2026.

Barclays PLC has updated its beneficial ownership filing for Everspin Technologies Inc., reporting a 1.89% stake as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting a 1.72% beneficial ownership in Bel Fuse Inc.'s common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting a 1.72% beneficial ownership in Bel Fuse Inc.'s common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Himalaya Shipping Ltd. common shares.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Himalaya Shipping Ltd. common shares.

Tassos Gianakakos reports beneficial ownership of 11.1% of Kardigan Inc. common stock as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.5% of Dave & Buster's Entertainment, Inc. common stock.